Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1738

1.

Quantification of Optic Nerve and Sheath Diameter by Transorbital Sonography: A Systematic Review and Metanalysis.

Schroeder C, Katsanos AH, Richter D, Tsivgoulis G, Gold R, Krogias C.

J Neuroimaging. 2020 Feb 5. doi: 10.1111/jon.12691. [Epub ahead of print]

PMID:
32022367
2.

Endocarditis following ocrelizumab in relapsing-remitting MS.

Faissner S, Schwake C, Gotzmann M, Mügge A, Schmidt S, Gold R.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 3;7(3). pii: e680. doi: 10.1212/NXI.0000000000000680. Print 2020 May. No abstract available.

3.

DeepWAS: Multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning.

Arloth J, Eraslan G, Andlauer TFM, Martins J, Iurato S, Kühnel B, Waldenberger M, Frank J, Gold R, Hemmer B, Luessi F, Nischwitz S, Paul F, Wiendl H, Gieger C, Heilmann-Heimbach S, Kacprowski T, Laudes M, Meitinger T, Peters A, Rawal R, Strauch K, Lucae S, Müller-Myhsok B, Rietschel M, Theis FJ, Binder EB, Mueller NS.

PLoS Comput Biol. 2020 Feb 3;16(2):e1007616. doi: 10.1371/journal.pcbi.1007616. eCollection 2020 Feb.

4.

Longitudinal Remote Coaching for Implementation of Perinatal Collaborative Care: A Mixed-Methods Analysis.

Bhat A, Bennett IM, Bauer AM, Beidas RS, Eriksen W, Barg FK, Gold R, Unützer J.

Psychiatr Serv. 2020 Jan 30:appips201900341. doi: 10.1176/appi.ps.201900341. [Epub ahead of print]

PMID:
31996114
5.

Management of pancreatic pseudocysts in pediatric oncology patients.

El-Gohary Y, Mansfield S, Staszak J, Abdelhafeez A, Talbot L, Pui CH, Gold R, Murphy AJ, Davidoff AM.

J Pediatr Surg. 2019 Dec 27. pii: S0022-3468(19)30875-9. doi: 10.1016/j.jpedsurg.2019.12.002. [Epub ahead of print]

PMID:
31954554
6.

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study.

Diem L, Daponte A, Findling O, Miclea A, Briner M, Salmen A, Gold R, Kilidireas C, Chan A, Evangelopoulos ME, Hoepner R.

Neurol Neuroimmunol Neuroinflamm. 2020 Jan 14;7(2). pii: e660. doi: 10.1212/NXI.0000000000000660. Print 2020 Mar.

7.

Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome : Coincidence or Relevant?

Kruczek P, Bellenberg B, Lutz T, Schneider R, Ahlborn C, Gold R, Köster O, Lukas C.

Clin Neuroradiol. 2020 Jan 2. doi: 10.1007/s00062-019-00869-y. [Epub ahead of print]

PMID:
31897504
8.

Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis.

Motte J, Fisse AL, Grüter T, Schneider R, Breuer T, Lücke T, Krueger S, Nguyen HP, Gold R, Ayzenberg I, Ellrichmann G.

BMC Neurol. 2019 Dec 29;19(1):345. doi: 10.1186/s12883-019-1583-0.

9.

Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.

Richter D, Katsanos AH, Schroeder C, Tsivgoulis G, Paraskevas GP, Müller T, Alexandrov AV, Gold R, Tönges L, Krogias C.

Cells. 2019 Dec 18;9(1). pii: E2. doi: 10.3390/cells9010002.

10.

Atrophy of optic nerve detected by transorbital sonography in patients with demyelinating diseases of the central nervous system.

Schroeder C, Katsanos AH, Ayzenberg I, Schwake C, Gahlen A, Tsivgoulis G, Voumvourakis K, Gold R, Krogias C.

Eur J Neurol. 2019 Dec 8. doi: 10.1111/ene.14137. [Epub ahead of print]

PMID:
31814240
11.

Does increased implementation support improve community clinics' guideline-concordant care? Results of a mixed methods, pragmatic comparative effectiveness trial.

Gold R, Bunce A, Cowburn S, Davis JV, Nelson JC, Nelson CA, Hicks E, Cohen DJ, Horberg MA, Melgar G, Dearing JW, Seabrook J, Mossman N, Bulkley J.

Implement Sci. 2019 Dec 5;14(1):100. doi: 10.1186/s13012-019-0948-5.

12.

Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.

Scherbaum R, Hartelt E, Kinkel M, Gold R, Muhlack S, Tönges L.

J Neurol. 2019 Dec 3. doi: 10.1007/s00415-019-09657-7. [Epub ahead of print]

PMID:
31797086
13.

Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis.

Haupeltshofer S, Leichsenring T, Berg S, Pedreiturria X, Joachim SC, Tischoff I, Otte JM, Bopp T, Fantini MC, Esser C, Willbold D, Gold R, Faissner S, Kleiter I.

Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25860-25869. doi: 10.1073/pnas.1905955116. Epub 2019 Dec 3.

PMID:
31796589
14.

[New therapeutic approaches in progressive multiple sclerosis].

Faissner S, Gold R.

Fortschr Neurol Psychiatr. 2019 Nov;87(11):653-671. doi: 10.1055/a-0880-0073. Epub 2019 Nov 29. Review. German.

PMID:
31783427
15.

Variation in Electronic Health Record Documentation of Social Determinants of Health Across a National Network of Community Health Centers.

Cottrell EK, Dambrun K, Cowburn S, Mossman N, Bunce AE, Marino M, Krancari M, Gold R.

Am J Prev Med. 2019 Dec;57(6S1):S65-S73. doi: 10.1016/j.amepre.2019.07.014.

16.

Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics Study.

Schneider R, Genç E, Ahlborn C, Gold R, Lukas C, Bellenberg B.

Front Neurol. 2019 Nov 5;10:1165. doi: 10.3389/fneur.2019.01165. eCollection 2019.

17.

Promoting Health on Social Media: The Way Forward.

Abroms LC, Gold RS, Allegrante JP.

Health Educ Behav. 2019 Dec;46(2_suppl):9-11. doi: 10.1177/1090198119879096. No abstract available.

PMID:
31742461
18.

Digital Health Communication Common Agenda 2.0: An Updated Consensus for the Public and Private Sectors to Advance Public Health.

Gold RS, Auld ME, Abroms LC, Smyser J, Yom-Tov E, Allegrante JP.

Health Educ Behav. 2019 Dec;46(2_suppl):124-128. doi: 10.1177/1090198119874086.

PMID:
31742457
19.

Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity.

Grüter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I.

J Neurol. 2019 Nov 22. doi: 10.1007/s00415-019-09614-4. [Epub ahead of print]

PMID:
31728710
20.

Early Multidisciplinary Intensive-care Therapy can Improve Outcome of Severe Anti-NMDA-receptor Encephalitis Presenting with Extreme Delta Brush.

Schneider R, Brüne M, Breuer TG, Börnke C, Gold R, Juckel G.

Transl Neurosci. 2019 Oct 2;10:241-243. doi: 10.1515/tnsci-2019-0039. eCollection 2019.

21.

Content and Feature Preferences for a Physical Activity App for Adults With Physical Disabilities: Focus Group Study.

Olsen SH, Saperstein SL, Gold RS.

JMIR Mhealth Uhealth. 2019 Oct 11;7(10):e15019. doi: 10.2196/15019.

22.

Progressive multiple sclerosis: latest therapeutic developments and future directions.

Faissner S, Gold R.

Ther Adv Neurol Disord. 2019 Sep 25;12:1756286419878323. doi: 10.1177/1756286419878323. eCollection 2019. Review.

23.

Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study.

Kramer S, Haghikia A, Bang C, Scherf K, Pfanne A, Duscha A, Kaisler J, Gisevius B, Gold R, Thum T, Haghikia A.

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 1;6(6):e623. doi: 10.1212/NXI.0000000000000623. Print 2019 Nov.

24.

Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis.

Pitarokoili K, Bachir H, Sgodzai M, Grüter T, Haupeltshofer S, Duscha A, Pedreiturria X, Motte J, Gold R.

Front Immunol. 2019 Sep 10;10:2132. doi: 10.3389/fimmu.2019.02132. eCollection 2019.

25.

National Data on Social Risk Screening Underscore the Need for Implementation Research.

Gold R, Gottlieb L.

JAMA Netw Open. 2019 Sep 4;2(9):e1911513. doi: 10.1001/jamanetworkopen.2019.11513. No abstract available.

26.

Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases.

Motte J, Kneiphof J, Straßburger-Krogias K, Pitarokoili K, Fisse AL, Kappos L, Gold R.

Ther Adv Neurol Disord. 2019 Aug 24;12:1756286419872115. doi: 10.1177/1756286419872115. eCollection 2019.

27.

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis.

Ayzenberg I, Ellrichmann G, Schroeder C, Tönges L, Klasing A, Pappa V, Brück W, Gold R.

Front Neurol. 2019 Aug 2;10:829. doi: 10.3389/fneur.2019.00829. eCollection 2019.

28.

Dermoscopy of primary cutaneous intravascular large B-cell lymphoma.

Llamas-Velasco M, Held L, Gold R, Paredes B.

Clin Exp Dermatol. 2019 Aug 16. doi: 10.1111/ced.14073. [Epub ahead of print] No abstract available.

PMID:
31419326
29.

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.

Faissner S, Plemel JR, Gold R, Yong VW.

Nat Rev Drug Discov. 2019 Dec;18(12):905-922. doi: 10.1038/s41573-019-0035-2. Epub 2019 Aug 9. Review.

PMID:
31399729
30.

Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data.

Sinnecker T, Hadisurya J, Schneider-Hohendorf T, Schwab N, Wrede K, Gembruch O, Gold R, Hellwig K, Pilgram-Pastor S, Adams O, Albrecht P, Hartung HP, Aktas O, Kraemer M.

BMC Neurol. 2019 Aug 9;19(1):190. doi: 10.1186/s12883-019-1407-2.

31.

Utilizing Student Health and Academic Data: A County-Level Demonstration Project.

Carter-Pokras OD, Bugbee BA, Gold RS, Lauver PE, Aiken R, Arria AM.

Health Promot Pract. 2019 Aug 9:1524839919862796. doi: 10.1177/1524839919862796. [Epub ahead of print]

PMID:
31394957
32.

Heterogeneous GBS course requires standardized guidelines.

Pitarokoili K, Gold R.

Nat Rev Neurol. 2019 Oct;15(10):561-562. doi: 10.1038/s41582-019-0245-6. No abstract available.

PMID:
31358946
33.

Fingolimod for Irradiation-Induced Neurodegeneration.

Metzdorf J, Hobloss Z, Schlevogt S, Ayzenberg I, Stahlke S, Pedreiturria X, Haupeltshofer S, Gold R, Tönges L, Kleiter I.

Front Neurosci. 2019 Jul 9;13:699. doi: 10.3389/fnins.2019.00699. eCollection 2019.

34.

[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany].

Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, Trebst C, Warnke C, Linker R, Kerschensteiner M, Zettl U, Tumani H, Brück W, Meuth SG, Kümpfel T, Hemmer B, Wiendl H, Gold R, Zipp F.

Nervenarzt. 2019 Dec;90(12):1245-1253. doi: 10.1007/s00115-019-0760-0. Review. German.

PMID:
31297574
35.

Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy.

Pitarokoili K, Sturm D, Labedi A, Greiner T, Eitner L, Kumowski N, Enax-Krumova EK, Fisse AL, Maier C, Gold R, Tegenthoff M, Schmidt-Wilcke T, Yoon MS.

Ther Adv Neurol Disord. 2019 Jun 18;12:1756286419855485. doi: 10.1177/1756286419855485. eCollection 2019.

36.

Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.

Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L.

J Neural Transm (Vienna). 2019 Jul;126(7):879-888. doi: 10.1007/s00702-019-02034-8. Epub 2019 Jun 20.

PMID:
31222604
37.

Cell sorting actuated by a microfluidic inertial vortex.

Pritchard RH, Zhukov AA, Fullerton JN, Want AJ, Hussain F, la Cour MF, Bashtanov ME, Gold RD, Hailes A, Banham-Hall E, Rogers SS.

Lab Chip. 2019 Jul 9;19(14):2456-2465. doi: 10.1039/c9lc00120d.

PMID:
31210196
38.

Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy.

Ambrosius B, Gold R, Chan A, Faissner S.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e551. doi: 10.1212/NXI.0000000000000551. eCollection 2019 May.

39.

Role of Health Information Technology in Addressing Health Disparities: Patient, Clinician, and System Perspectives.

Zhang X, Hailu B, Tabor DC, Gold R, Sayre MH, Sim I, Jean-Francois B, Casnoff CA, Cullen T, Thomas VA Jr, Artiles L, Williams K, Le PT, Aklin CF, James R.

Med Care. 2019 Jun;57 Suppl 6 Suppl 2:S115-S120. doi: 10.1097/MLR.0000000000001092.

PMID:
31095049
40.

Social Relationships and Functional Impairment in Aging Cancer Survivors: A Longitudinal Social Network Study.

Guida JL, Holt CL, Dallal CM, He X, Gold R, Liu H.

Gerontologist. 2019 May 3. pii: gnz051. doi: 10.1093/geront/gnz051. [Epub ahead of print]

PMID:
31050729
41.

Three cases of non-carryover fingolimod-PML: Is the risk in Japan increased?

Nakahara J, Tomaske L, Kume K, Takata T, Kamada M, Deguchi K, Kufukihara K, Schneider R, Gold R, Ayzenberg I.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 10;6(3):e559. doi: 10.1212/NXI.0000000000000559. eCollection 2019 May.

42.

Bringing Social Context into Diabetes Care: Intervening on Social Risks versus Providing Contextualized Care.

Hessler D, Bowyer V, Gold R, Shields-Zeeman L, Cottrell E, Gottlieb LM.

Curr Diab Rep. 2019 Apr 29;19(6):30. doi: 10.1007/s11892-019-1149-y. Review.

PMID:
31037356
43.

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.

Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kümpfel T, Linker RA, Paul F, Stangel M, Tackenberg B, Bergh FT, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Tumani H, Gold R, Hemmer B; German Competence Network of Multiple Sclerosis.

JAMA Neurol. 2019 Jul 1;76(7):841-849. doi: 10.1001/jamaneurol.2019.0905.

PMID:
31034002
44.

Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.

Hoepner R, Bagnoud M, Pistor M, Salmen A, Briner M, Synn H, Schrewe L, Guse K, Ahmadi F, Demir S, Laverick L, Gresle M, Worley P, Reichardt HM, Butzkueven H, Gold R, Metz I, Lühder F, Chan A.

Acta Neuropathol. 2019 Sep;138(3):443-456. doi: 10.1007/s00401-019-02018-8. Epub 2019 Apr 27.

45.

Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study.

Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Poole EM, Robinson M, Gold R.

Mult Scler Relat Disord. 2019 Jun;31:157-164. doi: 10.1016/j.msard.2019.03.022. Epub 2019 Mar 30.

46.

Functional Neurosonology Reveals Impaired Cerebrovascular Reactivity in Multiple Sclerosis.

Krogias C, Christou I, Tsivgoulis G, Koutroulou I, Schroeder C, Lantinioti C, Richter D, Karapanayiotides T, Haghikia A, Gold R, Voumvourakis K.

J Neuroimaging. 2019 Sep;29(5):589-591. doi: 10.1111/jon.12617. Epub 2019 Apr 16.

PMID:
30990241
47.

Priorities Wizard: Multisite Web-Based Primary Care Clinical Decision Support Improved Chronic Care Outcomes with High Use Rates and High Clinician Satisfaction Rates.

Sperl-Hillen JM, Rossom RC, Kharbanda EO, Gold R, Geissal ED, Elliott TE, Desai JR, Rindal DB, Saman DM, Waring SC, Margolis KL, O'Connor PJ.

EGEMS (Wash DC). 2019 Apr 3;7(1):9. doi: 10.5334/egems.284. Review.

48.

Author Correction: Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.

Masuda T, Sankowski R, Staszewski O, Böttcher C, Amann L, Sagar, Scheiwe C, Nessler S, Kunz P, van Loo G, Coenen VA, Reinacher PC, Michel A, Sure U, Gold R, Grün D, Priller J, Stadelmann C, Prinz M.

Nature. 2019 Apr;568(7751):E4. doi: 10.1038/s41586-019-1045-2.

PMID:
30918409
49.

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.

Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ.

Neurology. 2019 Apr 9;92(15):e1724-e1738. doi: 10.1212/WNL.0000000000007262. Epub 2019 Mar 27.

50.

A protein quality control pathway regulated by linear ubiquitination.

van Well EM, Bader V, Patra M, Sánchez-Vicente A, Meschede J, Furthmann N, Schnack C, Blusch A, Longworth J, Petrasch-Parwez E, Mori K, Arzberger T, Trümbach D, Angersbach L, Showkat C, Sehr DA, Berlemann LA, Goldmann P, Clement AM, Behl C, Woerner AC, Saft C, Wurst W, Haass C, Ellrichmann G, Gold R, Dittmar G, Hipp MS, Hartl FU, Tatzelt J, Winklhofer KF.

EMBO J. 2019 May 2;38(9). pii: e100730. doi: 10.15252/embj.2018100730. Epub 2019 Mar 18.

PMID:
30886048

Supplemental Content

Support Center